Ned Snyder
Gastroenterology · Houston, TXNPI 1568521953
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $628, 2.8 times the $223 reported in 2019. That places this record below the midpoint for gastroenterology clinicians in TX, where the typical reported total is $3,104.
Across 57 payments — averaging $29.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$244
- AbbVie$233
- Motiva USA, LLC$196
- Medtronic$168
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$161
- Johnson & Johnson$142
- plus $508 from 12 others
Across 4 payments — averaging $9000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$36K
What the payments were for
- Food & beverage$1,653100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $244 |
| AbbVie | 10 | $233 |
| Motiva USA, LLC | 1 | $196 |
| Medtronic | 3 | $168 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $161 |
| Johnson & Johnson(2 entities) | 3 | $142 |
| Standard Bariatrics, Inc. | 1 | $132 |
| Merck | 5 | $99 |
| Madrigal Pharmaceuticals | 2 | $53 |
| QOL Medical, LLC | 3 | $45 |
| Novo Nordisk | 1 | $34 |
| Alcresta Therapeutics, Inc. | 1 | $25 |
| Acelrx Pharmaceuticals, Inc. | 1 | $25 |
| Merz North America, Inc. | 1 | $24 |
| Sanofi | 1 | $24 |
| Gilead | 1 | $18 |
| Olympus America Inc. | 1 | $16 |
| Ardelyx, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,653 in reported general payments places this provider in the 35th percentile of 1,350 gastroenterology providers in Texas.
Other gastroenterology in Houston
- Bincy AbrahamHouston$1.6M
- Mazen NoureddinHouston$1.5M
- Stephen PappasHouston$1.4M
- Brooks CashHouston$867K
- Mohamed OthmanHouston$777K
- Isaac RaijmanHouston$565K
- Kalpesh PatelHouston$382K
- Victor Ankoma-SeyHouston$340K
- John VierlingHouston$270K
- George TriadafilopoulosHouston$192K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.